General Notices

• Notice of Pre-Application Webinar for Funding Opportunity RFA-AG-23-016, "Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)"
  (NOT-AG-23-038)
  National Institute on Aging
  

• Notice of Correction to the Application Types Allowed Information for RFA-AG-23-016, Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
  (NOT-AG-23-041)
  National Institute on Aging
  

• Request for Information (RFI): Soliciting data on the impact of telehealth initiation of controlled substances permitted under the COVID-19 Public Health Emergency (PHE)
  (NOT-DA-23-028)
  National Institute on Drug Abuse
  

Notice of Changes to Funding Opportunities

• Notice of NIDA Participation in RFA-NS-22-022, RFA-NS-22-023, RFA-NS-22-024, RFA-NS-22-025, "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research"
  (NOT-DA-23-026)
  National Institute on Drug Abuse
  

• Notice of Clarification to PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
  (NOT-DA-23-029)
  National Institute on Drug Abuse
  

• Notice of Change to Key Dates for RFA-NS-24-009: Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
  (NOT-NS-24-007)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Correction to modify the label to R&R Budget" for RFA-RM-23-005 "NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)"
  (NOT-RM-23-020)
  Office of Strategic Coordination (Common Fund)
  

• Notice to Extend the Due Date and Expiration Date of NOT-TR-23-019: Notice of Special Interest (NOSI): Availability of Administrative Supplements for Submission to the ASPIRE (A Specialized Platform for Research Exploration) Collaborative Research Program
  (NOT-TR-23-025)
  National Center for Advancing Translational Sciences
  

Notices of Intent to Publish

• Notice of Intent to Publish the Reissuance of RFA-AG-23-003, "Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)"
  (NOT-AG-23-036)
  National Institute on Aging
  

Requests for Proposal

• Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
  (NOT-OD-23-142)
  Office of the Director, NIH
  

• Extramural Loan Repayment Program for Pediatric Research (LRP-PR)
  (NOT-OD-23-143)
  Office of the Director, NIH
  

• Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
  (NOT-OD-23-144)
  Office of the Director, NIH
  

• Extramural Loan Repayment Program for Research in Emerging Areas Critical to Human Health (LRP-REACH)
  (NOT-OD-23-145)
  Office of the Director, NIH
  

• Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
  (NOT-OD-23-146)
  Office of the Director, NIH
  

• Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
  (NOT-OD-23-147)
  Office of the Director, NIH
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Advancing Research to Address the Heterogeneity of Obesity Risk, Related Health Outcomes, and Response to Treatment
  (NOT-HL-23-090)
  National Heart, Lung, and Blood Institute
  

Funding Opportunities

• Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)
  (RFA-AG-24-039)
  National Institute on Aging
  Application Receipt Date(s): November 02, 2023
  
  

• Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required)
  (RFA-AG-24-048)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2023
  
  

• Single Source : NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
  (RFA-EB-23-003)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): September 26, 2023
  
  

• Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
  (RFA-ES-23-011)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): December 01, 2025
  
  

• ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed)
  (RFA-OD-23-018)
  Office of Disease Prevention
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): October 31, 2023
  
  

• Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
  (RFA-TR-23-016)
  National Center for Advancing Translational Sciences
  National Institute of Mental Health
  Application Receipt Date(s): June 02, 2025